![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1672723
³»ºÐºñ °Ë»ç Á¦Ç° ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ÀûÀÀ Áúȯº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°Endocrine Testing Product Market, By Product Type, By Technology, By Disease Indication, By End User, By Geography |
¼¼°èÀÇ ³»ºÐºñ °Ë»ç Á¦Ç° ½ÃÀåÀº 2025³â¿¡´Â 149¾ï 8,000¸¸ ´Þ·¯¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. 2032³â¿¡´Â 281¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ °ÉÃÄ CAGR 9.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ ¼¼ºÎÁ¤º¸ | ||
---|---|---|---|
±âÁØ ¿¬µµ | 2024³â | 2025³â ½ÃÀå ±Ô¸ð | 149¾ï 8,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2020-2024³â | ¿¹Ãø ±â°£ | 2025-2032³â |
¿¹Ãø ±â°£(2025-2032³â) CAGR | 9.40% | 2032³â ±Ý¾× ¿¹Ãø | 281¾ï 1,000¸¸ ´Þ·¯ |
³»ºÐºñ °Ë»ç Á¦Ç°Àº ³»ºÐºñ ½Ã½ºÅÛÀÇ ±â´É °Ë»ç¿¡ »ç¿ëµÇ´Â ü¿Ü Áø´ÜÁ¦ÀÔ´Ï´Ù. ³»ºÐºñ ½Ã½ºÅÛÀº È£¸£¸óÀ» ¼øÈ¯°è·Î Á÷Á¢ ºÐºñÇÏ¿© ¸Õ Ç¥Àû Àå±â¸¦ Á¶ÀýÇÏ´Â ¶¡»ùÀ¸·Î ±¸¼ºµÈ Á¶Àý ½Ã½ºÅÛÀÔ´Ï´Ù. ³»ºÐºñ °Ë»ç Á¦Ç°Àº Àǻ簡 È£¸£¸ó ¼öÁØÀ» ¸ð´ÏÅ͸µÇÏ°í ³»ºÐºñ ÁúȯÀ» ½ºÅ©¸®´×ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀϹÝÀûÀÎ ³»ºÐºñ °Ë»ç¿¡´Â °©»ó¼± ±â´É °Ë»ç, Å×½ºÅ佺Å×·Ð °Ë»ç, ¿¡½ºÆ®·Î°Õ °Ë»ç, ÇÁ·Î¶ôƾ °Ë»ç, ÄÚÆ¼¼Ö °Ë»ç, Àν¶¸° °Ë»ç µîÀÌ ÀÖ½À´Ï´Ù. ´ç´¢º´, °©»ó¼± Àå¾Ö, È£¸£¸ó ºÒ±ÕÇü Àå¾Ö¿Í °°Àº ³»ºÐºñ °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Àü ¼¼°èÀûÀ¸·Î ³»ºÐºñ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. Áø´Ü ±â¼úÀÇ Áøº¸·Î ÀÓ»ó ½ÇÇè½Ç¿¡¼ °í°¨µµ ¹ÙÀÌ¿À ºÐ¼® ¹× °í¼º´É ³»ºÐºñ °Ë»ç¸¦ À§ÇÑ ÀÚµ¿È ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
¼¼°èÀÇ ³»ºÐºñ °Ë»ç Á¦Ç° ½ÃÀå ¼ºÀåÀº ³»ºÐºñ ÁúȯÀÌ ¹ßº´Çϱ⠽¬¿î ³ëÀÎ Áõ°¡, ³»ºÐºñ Áúȯ¿¡ ´ëÇÑ Àνİú ½ºÅ©¸®´× Áõ°¡, Áúº´ Áø´Ü ¹× °ü¸®¿¡¼ ³»ºÐºñ ±â´É °Ë»çÀÇ ÀÀ¿ë È®´ë¿¡ ÀÇÇØ ¾ß±âµË´Ï´Ù. ±×·¯³ª ½ÅÁ¦Ç° ½ÂÀÎÀ» À§ÇÑ ±æ°í º¹ÀâÇÑ ±ÔÁ¦ °úÁ¤°ú ±âÁ¸ °Ë»ç ÀýÂ÷ÀÇ º¯È¿¡ ´ëÇÑ ±àÁ¤ÀûÀΠŵµ´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº Á¤¹Ðµµ Çâ»ó, ÇÑ ¹øÀÇ °Ë»ç·®, ÅëÇÕµÈ ÀÎÆ÷¸Åƽ½º¸¦ °®Ãá ÷´Ü ¸é¿ª ÃøÁ¤ Ç÷§Æû °³¹ßÀ» ÅëÇØ À¯¸®ÇÑ ±âȸ¸¦ È®ÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¸°ÔÇÏ¸é ¼Ò·®ÀÇ »ùÇ÷Π¿©·¯ È£¸£¸óÀ» µ¿½Ã¿¡ °Ë»çÇÒ ¼ö ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
º» º¸°í¼¿¡¼´Â ¼¼°èÀÇ ³»ºÐºñ °Ë»ç Á¦Ç° ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª¿¡ ÀÇÇÑ Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
¼¼°èÀÇ ³»ºÐºñ °Ë»ç Á¦Ç° ½ÃÀå ÁÖ¿ä ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷Àº Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc., Danaher, Immunodiagnostic Systems, Fujirebio, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ³»ºÐºñ °Ë»ç Á¦Ç° ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°èÀÇ ³»ºÐºñ °Ë»ç Á¦Ç° ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.
Global Endocrine Testing Product Market is estimated to be valued at USD 14.98 Bn in 2025 and is expected to reach USD 28.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 14.98 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 9.40% | 2032 Value Projection: | USD 28.11 Bn |
Endocrine testing product refers to in vitro diagnostics that are used to test the functionality of the endocrine system. Endocrine system is a regulatory system composed of glands that secrete hormones directly into the circulatory system to regulate distant target organs. Endocrine testing products help physicians monitor hormone levels and screen for endocrine disorders. Some common endocrine tests include thyroid function tests, testosterone testing, estrogen testing, prolactin testing, cortisol testing, and insulin testing. Rising prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and hormonal imbalance disorders can boost demand for endocrine testing worldwide. Advancements in diagnostic technologies have enabled the development of sensitive bioassays and automated solutions for high-throughput endocrine testing in clinical laboratories.
Global endocrine testing product market growth is driven by growing geriatric population who are more prone to developing endocrine disorders, increasing awareness and screening of endocrine conditions, and expanding applications of endocrine function tests in disease diagnosis and management. However, lengthy and complex regulatory processes for new product approvals and reluctance to change existing testing procedures can hamper the market growth. The market witness lucrative opportunities from the development of advanced immunoassay platforms with improved accuracy, high test volumes per run, and integrated informatics. This allows for the testing of multiple hormones simultaneously using small sample volumes.
Key Features of the Study
This report provides in-depth analysis of the global endocrine testing product market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global endocrine testing product market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, Immunodiagnostic Systems, and Fujirebio, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global endocrine testing product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing product market